News
Abbott Laboratories (NYSE: ABT) is scheduled to announce Q2 earnings results on Thursday, July 17th, before market open.
Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shared insights on. While discussing the stock, Cramer ...
StockStory.org on MSN1d
Abbott Laboratories (ABT) Q2 Earnings: What To ExpectHealthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results this Thursday ...
Prominent healthcare entrepreneur Ron Zwanziger approached medical device maker OraSure Technologies with a takeover offer, ...
Abbott Laboratories closed 6.52% below its 52-week high of $141.23, which the company reached on March 4th.
Abbott Laboratories ABT is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...
Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $158 to $159 on April 17, ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
2d
Zacks Investment Research on MSNABT to Report Q2 Earnings: CGM and Cardiac Devices in FocusAbbott Laboratories ABT is slated to report second-quarter 2025 results on July 17, before the opening bell. The company delivered adjusted earnings per share (EPS) of $1.09 in the last quarter, which ...
Gov. Greg Abbott showed his continued fundraising dominance in a campaign finance report, indicating a $20 million haul.
Texas Gov. Greg Abbott raised $20 million over eight days in June, with several $1 million checks from GOP megadonors.
Abbott updated Texas’ disaster declaration to include five more counties; FEMA expands Public Assistance for flood recovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results